Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Apogee Therapeutics (APGE) SEC Filings & 10K Form

Apogee Therapeutics logo
$37.29 -0.83 (-2.18%)
Closing price 04:00 PM Eastern
Extended Trading
$37.44 +0.15 (+0.40%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Apogee Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/11/2025
6:30 AM		Apogee Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2025
6:15 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2025
7:00 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
12:35 PM		Apogee Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
08/05/2025
12:44 PM		Apogee Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
07/16/2025
6:02 PM		Apogee Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
07/07/2025
5:06 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2025
7:00 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
3:22 PM		Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2025
7:00 PM		Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
7:01 PM		Apogee Therapeutics (Issuer)
Fox Jennifer A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
7:02 PM		Apogee Therapeutics (Issuer)
Gottesdiener Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
7:03 PM		Apogee Therapeutics (Issuer)
JONES WILLIAM A JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
7:04 PM		Apogee Therapeutics (Issuer)
McKenna Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
7:05 PM		Apogee Therapeutics (Issuer)
Shah Nimish P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
7:06 PM		Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
7:01 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
9:44 AM		Apogee Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/12/2025
5:30 AM		Apogee Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2025
5:15 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2025
7:01 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
3:15 PM		Apogee Therapeutics (Filer)
Form DEF 14A
04/04/2025
7:01 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
5:30 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
7:01 PM		Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:02 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
12:46 PM		Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
6:06 AM		Apogee Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
6:12 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
5:30 AM		Apogee Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
8:00 AM		Apogee Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G
02/07/2025
7:01 PM		Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
7:02 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
1:02 PM		Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:05 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2025
7:00 PM		Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:00 PM		Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
11:23 AM		Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/03/2025
7:00 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
5:00 AM		Apogee Therapeutics (Issuer)
McKenna Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
7:01 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.

Watch the National Emergency broadcast here
12/11/2024
7:01 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:02 PM		Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:02 PM		Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:59 PM		Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
6:30 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
7:01 PM		Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
7:02 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
10:12 AM		Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
5:17 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:46 PM		Apogee Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
10:16 AM		Apogee Therapeutics (Subject)
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
11/14/2024
9:18 AM		Apogee Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/12/2024
6:15 AM		Apogee Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
6:05 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:01 PM		Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
7:02 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
10:39 AM		Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
6:59 PM		ACCESS INDUSTRIES MANAGEMENT, LLC (Filed by)
Apogee Therapeutics (Subject)
Form SC 13G/A
10/24/2024
7:10 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM		Apogee Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/04/2024
7:01 PM		Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
7:02 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
9:05 AM		Apogee Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
10/02/2024
3:20 PM		Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
1:34 PM		Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
7:02 PM		Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
7:03 PM		Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
12:35 PM		Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
7:05 PM		Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:29 AM		Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:APGE) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored